Document is current
Any future updates will be listed below
-
Authors
Yin, Yongmei https://orcid.org/0000-0003-3335-369X
Fan, Ying
Ouyang, Quchang
Song, Lihua
Wang, Xiaojia https://orcid.org/0000-0002-7005-0842
Li, Wei
Li, Man
Yan, Xi
Wang, Shusen https://orcid.org/0000-0003-0139-5780
Sun, Tao
Teng, Yuee
Tang, Xianjun
Tong, Zhongsheng
Sun, Zhengkui
Ge, Junyou
Jin, Xiaoping
Diao, Yina
Liu, Gesha
Xu, Binghe https://orcid.org/0000-0003-4195-337X
- License Information
-
More Information
Article History
Received: 27 October 2024
Accepted: 4 March 2025
First Online: 11 April 2025
Competing interests
: B.X. has served as advisor or consultant for Novartis and AstraZeneca. J.G., X.J., Y.D. and G.L. are employees of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. The other authors declare no competing interests.
